Reluctance to explore may limit learning for students from less affluent backgrounds.
Reluctance to explore may limit learning for students from less affluent backgrounds.
Combining bevacizumab with erlotinib shrinks tumors in patients with aggressive, HLRCC-associated kidney cancers.
Researchers have learned how neurons in the brain can be damaged by the chemotherapy drug Ara-C.
Liver cells divvy up metabolic tasks to take advantage of available nutrients.
A genome-wide screen drills down to gene segments to find out which ones matter for cell fitness.
A novel therapy helps eliminate recurring respiratory growths in patients — and the frequent surgeries they required.
Full story at National Cancer Institute
Images of a bacterial motor show how it can reverse direction with the flip of a biological switch.
Full story at National Cancer Institute
A personalized approach to cellular immunotherapy helps shrink solid tumors.
Having more diverse HLA genes is better for immune control of HIV.